Bicycle Therapeutics PLC

Travis Thompson’s 58,000‑share option buy at Bicycle Therapeutics signals long‑term confidence despite recent sales—an insider move worth watching for future upside.

COO Milnes Alistair’s January 2026 RSU award and option purchase signal strategic confidence in Bicycle Therapeutics’ future, hinting at potential upside despite current market volatility.